INDUCTION OF APOPTOSIS BY PROTEASE-DEFECTIVE PARTICLE PREPARATIONS OFHUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS SPECIFIC TO A SUBSET OF U937-DERIVED SUBCLONES
M. Kameoka et al., INDUCTION OF APOPTOSIS BY PROTEASE-DEFECTIVE PARTICLE PREPARATIONS OFHUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS SPECIFIC TO A SUBSET OF U937-DERIVED SUBCLONES, International immunology, 8(11), 1996, pp. 1687-1697
Several recent reports support the hypothesis that apoptosis occurring
in leukocytes of human immunodeficiency virus type 1 (HIV-1)-infected
individuals is important in progression to AIDS. Specifically, apopto
sis of uninfected bystander cells appears critical in the pathogenesis
of disease. Here, we present evidence that protease-defective, gp120-
containing HIV-1 (L-2) particle preparations specifically induce apopt
osis in cells obtained from a subset of promonocytic U937-derived subc
lones, The rate of apoptosis induction was inversely correlated with t
he susceptibility of the U937 subclones to wild-type HIV-1 infection.
Three types of apoptosis experiments were performed: DNA content analy
sis by flow cytometry, apoptotic nuclear degradation by fluorescent mi
croscopy and DNA fragmentation analysis by agarose gel electrophoresis
. Kinetic analysis revealed that there was a slower induction of apopt
osis by L-2 particle preparations than with tumor necrosis factor (TNF
)-alpha or anti-fas antibody. However, there were no significant diffe
rences in the initial binding rates of L-2 particles as well as the bi
nding of TNF-alpha or anti-fas antibody to the U937 subclones. The bas
al level of protein kinase C activity was higher in high-type subclone
s compared with low-type subclones. These results suggest that U937 ce
lls can be divided into at least two subpopulations, one that permits
a productive HIV-1 infection but is not subjected to L-2 particle prep
aration-induced apoptosis, while the other poorly replicates HIV-1 and
is subjected to L-2 mediated apoptosis, although at a slower rate tha
n found with TNF-alpha or anti-fas antibody.